Elsevier Inc.

SHERPA: Unknown

People

  1. Ladanyi
    Ladanyi
  2. Hsu
    Hsu
  3. Kris
    Kris
  4. Berger
    Berger
  5. Giralt
    Giralt
  6. Perales
    Perales
  7. Riely
    Riely
  8. Hanash
    Hanash
  9. Peled
    Peled
  10. Solit
    Solit

Groups

  1. Human Oncology and Pathogenesis Program (420)
  2. GSK Faculty (394)
  3. Department of Medicine (340)
  4. Tow Center for Developmental Oncology (TCDO) (187)
  5. Department of Pathology and Laboratory Medicine (184)
  6. Solid Tumor Oncology Division (182)
  7. Center for Hematologic Malignancies (166)
  8. Hematologic Malignancies, Division of (151)
  9. Sloan Kettering Institute Postdocs (125)
  10. Bone Marrow Transplant (116)
Search Within
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (205)
  2. Meeting Abstract (182)
  3. Review (14)
  4. Book Section (9)
  5. Editorial (8)
  6. Conference Paper (1)
  7. Guidelines (1)
Groups
  1. Human Oncology and Pathogenesis Program (420)
  2. GSK Faculty (394)
  3. Department of Medicine (340)
  4. Tow Center for Developmental Oncology (TCDO) (187)
  5. Department of Pathology and Laboratory Medicine (184)
  6. Solid Tumor Oncology Division (182)

More Groups

People
  1. Marc Ladanyi (97)
  2. Marcel Van Den Brink (61)
  3. Katharine Hsu (52)
  4. Mark Kris (44)
  5. Michael Berger (38)
  6. Miguel-Angel Perales (37)

More People

Years
  1. 2025 (13)
  2. 2024 (32)
  3. 2023 (26)
  4. 2022 (27)
  5. 2021 (24)
  6. 2020 (25)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (100)
  2. Journal of Thoracic Oncology (89)
  3. Urologic Oncology: Seminars and Original Investigations (31)
  4. European Journal of Cancer (30)
  5. International Journal of Radiation Oncology, Biology, Physics (18)
  6. Transplantation and Cellular Therapy (13)

More Publications

Results (420)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy
    Journal Article

    Hsu, K. C.; Gooley, T.; Malkki, M.; Pinto-Agnello, C.; Dupont, B.; Bignon, J. D.; Bornhauser, M.; Christiansen, F.; Gratwohl, A.; Morishima, Y.; more...
    Biology of Blood and Marrow Transplantation (2006)

    Fulltext@MSK | Save
  • Immunity to fungi
    Journal Article

    Hohl, T. M.; Rivera, A.; Pamer, E. G.
    Current Opinion in Immunology (2006)

    Fulltext@MSK | Save
  • Missing killer immunoglobulin-like receptor (KIR) ligand confers protection from relapse in recipients of unrelated hematopoietic cell transplantation (HCT) for AML
    Meeting Abstract

    Hsu, K. C.; Malkki, M.; Gooley, T. A.; Dupont, B.; Petersdorf, E. W.
    Biology of Blood and Marrow Transplantation (2005)

    Fulltext@MSK | Save
  • Fludarabine-based conditioning secures engraftment of secondary hematopoietic stem cell allografts (HSCT) used to treat graft failure
    Meeting Abstract

    Chewning, J. H.; Castro-Malaspina, H. R.; Hsu, K.; Jakubowski, A. A.; Kernan, N. A.; Papadopoulos, E. B.; Perales, M. A.; Prockop, S. E.; Small, T. N.; van den Brink, M. R. M.; more...
    Biology of Blood and Marrow Transplantation (2005)

    Fulltext@MSK | Save
  • Translocation carcinomas of the kidney
    Journal Article

    Argani, P.; Ladanyi, M.
    Clinics in Laboratory Medicine (2005)

    Fulltext@MSK | Save
  • AML patients lacking KIR ligand for donor KIR exhibit increased overall survival in HLA-identical sibling transplants
    Meeting Abstract

    Hsu, K. C.; Taylor, C. A.; O'Reilly, R. J.; Horowitz, M. M.; Arkun, K.; Pinto, C.; Dupont, B.
    Biology of Blood and Marrow Transplantation (2004)

    Fulltext@MSK | Save
  • A phase II trial of a non-myeloablative regimen combining in vivo T cell depletion with an anti-CD52 monoclonal antibody (alemtuzumab), and chemotherapy with fludarabine and melphalan prior to a related or unrelated hematopoietic stem cell transplantation
    Meeting Abstract

    Castro-Malaspina, H.; Papadopoulos, E.; Jakubowski, A.; Perales, M. A.; Young, J.; Hsu, K.; Boulad, F.; Prasad, V.; Small, T.; Kernan, N.; more...
    Biology of Blood and Marrow Transplantation (2004)

    Fulltext@MSK | Save
  • Inhibitory killer Ig-like receptor genes and human leukocyte antigen class I ligands in haematopoietic stem cell transplantation
    Journal Article

    Dupont, B.; Hsu, K. C.
    Current Opinion in Immunology (2004)

    Fulltext@MSK | Save
  • Hsp90: The vulnerable chaperone
    Journal Article

    Chiosis, G.; Vilenchik, M.; Kim, J.; Solit, D.
    Drug Discovery Today (2004)

    Fulltext@MSK | Save
  • Targeting wide-range oncogenic transformation via PU24FCI, a specific inhibitor of tumor Hsp90
    Journal Article

    Vilenchik, M.; Solit, D.; Basso, A.; Huezo, H.; Lucas, B.; He, H.; Rosen, N.; Spampinato, C.; Modrich, P.; Chiosis, G.
    Chemistry and Biology (2004)

    Fulltext@MSK | Save